Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma
K.C. Chan, J.M. Yee Ko, and K.L. Lung Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma Int J Cancer 129 2011 1826 1837
Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy
C. Smith, J. Tsang, and L. Beagley Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy Cancer Res 72 2012 1116 1125
Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
D.M. Brizel, G.S. Sibley, and L.R. Prosnitz Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int J Radiat Oncol Biol Phys 38 1997 285 289
The genetics of mammalian circadian order and disorder: Implications for physiology and disease
J.S. Takahashi, H.K. Hong, and C.H. Ko The genetics of mammalian circadian order and disorder: Implications for physiology and disease Nat Rev Genet 9 2008 764 775
Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: A prospective randomized trial of the national cancer institute of Canada Clinical Trials Group (HN3)
G.A. Bjarnason, R.G. Mackenzie, and A. Nabid Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: A prospective randomized trial of the national cancer institute of Canada Clinical Trials Group (HN3) Int J Radiat Oncol Biol Phys 73 2009 166 172
Circadian variation of plasma cortisol and whole blood reduced glutathione levels in nasopharyngeal carcinoma patients
M.W. Wu, Z.L. Zeng, and S. Li Circadian variation of plasma cortisol and whole blood reduced glutathione levels in nasopharyngeal carcinoma patients Chin J Cancer 27 2008 237 242
The circadian gene expression of Per1 and Per2 and their influence on radiotherapeutic sensitivity of glioma in vitro
H.C. Xia, F. Wang, and Y.H. Li The circadian gene expression of Per1 and Per2 and their influence on radiotherapeutic sensitivity of glioma in vitro Future Neurol 7 2012 341 348
Chronotherapy and the molecular clock: Clinical implications in oncology
P.F. Innominato, F.A. Levi, and G.A. Bjarnason Chronotherapy and the molecular clock: Clinical implications in oncology Adv Drug Delivery Rev 62 2010 979 1001